ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;88:271-273. doi:10.1016/j.athoracsur.2008.12.036
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gordan Samoukovic
Renzo Cecere
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Samoukovic, G.
Right arrow Articles by Cecere, R.
PubMed
Right arrow Articles by Samoukovic, G.
Right arrow Articles by Cecere, R.
Related Collections
Right arrow Mechanical Circulatory Assistance
Right arrow Transplantation - heart


Case Reports

Successful Treatment of Heart Failure due to Acute Transplant Rejection With the Impella LP 5.0

Gordan Samoukovic, MDa, Talal Al-Atassi, BSca, Cristian Rosu, MDa, Nadia Giannetti, MDb, Renzo Cecere, MDa,*

a Division of Cardiothoracic Surgery, McGill University Health, Montreal, Quebec, Canada
b Division of Cardiology, McGill University Health, Montreal, Quebec, Canada

Accepted for publication December 1, 2008.

* Address correspondence to Dr Cecere, 687 Pine Ave West, Rm S8.45, Montreal, Quebec, H3A 1A1, Canada (Email: renzo.cecere{at}muhc.mcgill.ca).

Cardiogenic shock resulting from transplant rejection is a serious complication with high mortality and morbidity. Often resistant to maximal medical therapy, this condition frequently requires mechanical circulatory support until recovery or retransplantation. We present a 52-year-old patient with multiorgan failure secondary to acute graft rejection after orthotopic heart transplantation. Maximal medical therapy was not successful, and the patient was bridged to recovery with an Impella LP 5.0 (Abiomed Inc, Danvers, MA) left ventricular assist device (LVAD). The relative merits of this therapeutic approach are outlined and discussed. The patient was discharged 3 weeks after LVAD removal and remains clinically stable.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.